Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | Gregg Vicky B | Director | Sell | 1,250 | $191.76 | $239,700.00 | -6.8% | → |
| 2025-11-25 | Davis J. E. | CEO and President | Sale+OE | 55,093 | $192.22 | $10,589,759.82 | -11.8% | → |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sale+OE | 7,946 | $187.35 | $1,488,683.10 | -51.3% | → |
| 2025-10-22 | PFEIFFER GARY M | Director | Sell | 1,482 | $182.40 | $270,316.80 | -4.8% | → |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 227 | $188.13 | $42,706.01 | -0.3% | → |
| 2025-09-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 28,463 | $187.12 | $5,326,041.82 | -27.2% | → |
| 2025-08-21 | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $185.00 | $365,375.00 | -11.5% | → |
| 2025-08-19 | Plewman Patrick | SVP for Diagnostic Services | Sale+OE | 4,532 | $183.00 | $829,356.00 | -20.8% | → |
| 2025-08-15 | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $180.00 | $355,500.00 | -10.3% | → |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Sale+OE | 5,535 | $175.00 | $968,625.00 | -12.0% | → |
| 2025-07-31 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sale+OE | 10,479 | $167.95 | $1,759,930.60 | -26.0% | → |
| 2025-05-13 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 1,748 | $175.52 | $306,800.22 | -9.9% | → |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 39,191 | $168.46 | $6,602,074.29 | -1.8% | → |
| 2025-04-02 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2,555 | $170.00 | $434,350.00 | -19.5% | → |
| 2025-03-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,643 | $170.00 | $789,310.00 | -10.9% | → |
| 2025-03-05 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5,370 | $174.13 | $935,078.10 | -7.3% | → |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 592 | $175.79 | $104,067.68 | -1.5% | → |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 716 | $175.79 | $125,865.64 | -1.0% | → |
| 2025-02-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 528 | $172.61 | $91,138.08 | -1.3% | → |
| 2025-02-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 824 | $172.61 | $142,230.64 | -1.2% | → |
| 2025-02-20 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,434 | $170.51 | $244,514.86 | -1.0% | → |
| 2025-02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 604 | $170.99 | $103,277.96 | -1.5% | → |
| 2025-02-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 320 | $169.71 | $54,307.20 | -1.7% | → |
| 2025-02-05 | Gregg Vicky B | Director | Sell | 1,250 | $164.57 | $205,710.00 | -6.9% | → |
| 2025-02-05 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 403 | $164.30 | $66,214.15 | -8.0% | → |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 35,146 | $163.07 | $5,731,301.51 | -24.4% | → |